ArticleInternational braz j urol : official journal of the Brazilian Society of Urology
Patient-reported Outcomes of Transperineal Reanastomosis for Recurrent or Obliterative Post-prostatectomy Vesicourethral Anastomotic Stenosis.
Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePost-prostatectomy vesicourethral anastomotic stenosis (VUAS) affects up to 5% of patients. A subset of cases remains refractory to endoscopic treatment, significantly impacting quality of life in the long-term. This study presents 15-year follow-up data on patients undergoing open reanastomosis for refractory or obliterative VUAS. PATIENTS AND
methodsWe included patients who underwent transperineal vesicourethral reanastomosis from 2009-2023. The procedure was often staged, with artificial urinary sphincter (AUS) implantation three months later. Co-primary endpoints included retreatment-free survival (RFS) and patient-reported outcome measures (PROMs). RFS was analyzed with Kaplan-Meier estimators, and PROMs were evaluated per scoring manuals. Additionally, we conducted a scoping review of all studies reporting outcomes following complex VUAS reconstruction.
resultsAmong 46 patients with VUAS, prior endoscopic interventions included dilation (17%), incision (61%), and resection (80%). Median time from prostatectomy to reanastomosis was 23 months (IQR 16-42). At a median follow-up of 80 months (IQR 41-149), RFS rates were 91% at two years and 88% at five years. 30 patients (65%) required staged AUS implantation for stress urinary incontinence. PROMs, assessed in 28 patients (61%), indicated restored voiding function, absence of fecal incontinence, high treatment satisfaction, and low decision regret. Limitations include the absence of preoperative PROMs for baseline comparisons. The scoping review revealed varying success rates ranging from 60% to 92% and a significant underuse of validated PROMs.
conclusionsTransperineal reanastomosis offers an effective and lasting solution for treating recurrent or obliterative VUAS, with encouraging long-term results and favorable patient-reported outcomes, underscoring its critical role in salvage posterior urethral reconstruction after prostatectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.